| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Financière de Tubize SA (BR: TUB)
TUB Technical Analysis
5
| As on 16th Jan 2026 TUB STOCK Price closed @ 235.50 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 148.33 & Strong Buy for SHORT-TERM with Stoploss of 145.15 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TUBSTOCK Price
| Open | 232.00 | Change | Price | % |
| High | 238.00 | 1 Day | 5.00 | 2.17 |
| Low | 231.50 | 1 Week | 9.00 | 3.97 |
| Close | 235.50 | 1 Month | 24.50 | 11.61 |
| Volume | 32107 | 1 Year | 99.30 | 72.91 |
| 52 Week High 239.50 | 52 Week Low 103.80 | ||||
BR Belgium Most Active Stocks
| SCHD | 27.64 | 7.51% |
| OPTI | 0.01 | % |
| ABI | 59.08 | -0.30% |
| BOTHE | 0.29 | 70.59% |
| ACPH | 0.89 | 0.00% |
| UMI | 19.04 | -0.83% |
| SOLB | 27.12 | -1.45% |
| WDP | 23.74 | 1.02% |
| SEQUA | 0.54 | -1.82% |
| PROX | 7.25 | -1.49% |
BR Belgium Top Gainers Stocks
BR Belgium Top Losers Stocks
| TUB Daily Charts |
TUB Intraday Charts |
Whats New @ Bazaartrend |
TUB Free Analysis |
|
|
TUB Important Levels Intraday
| RESISTANCE | 248.03 |
| RESISTANCE | 244.01 |
| RESISTANCE | 241.53 |
| RESISTANCE | 239.04 |
| SUPPORT | 231.96 |
| SUPPORT | 229.47 |
| SUPPORT | 226.99 |
| SUPPORT | 222.97 |
TUB Forecast January 2026
| 4th UP Forecast | 267.87 |
| 3rd UP Forecast | 257.49 |
| 2nd UP Forecast | 251.07 |
| 1st UP Forecast | 244.66 |
| 1st DOWN Forecast | 226.34 |
| 2nd DOWN Forecast | 219.93 |
| 3rd DOWN Forecast | 213.51 |
| 4th DOWN Forecast | 203.13 |
TUB Weekly Forecast
| 4th UP Forecast | 248.99 |
| 3rd UP Forecast | 244.66 |
| 2nd UP Forecast | 241.99 |
| 1st UP Forecast | 239.32 |
| 1st DOWN Forecast | 231.69 |
| 2nd DOWN Forecast | 229.01 |
| 3rd DOWN Forecast | 226.34 |
| 4th DOWN Forecast | 222.01 |
TUB Forecast2026
| 4th UP Forecast | 501.81 |
| 3rd UP Forecast | 416.4 |
| 2nd UP Forecast | 363.61 |
| 1st UP Forecast | 310.82 |
| 1st DOWN Forecast | 160.18 |
| 2nd DOWN Forecast | 107.39 |
| 3rd DOWN Forecast | 54.6 |
| 4th DOWN Forecast | -30.81 |
Financière de Tubize SA ( BR Belgium Symbol : TUB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TUB Business Profile
Financière de Tubize S.A., through its interest in UCB, operates as a biopharmaceutical company worldwide. It discovers and develops medicines and solutions in the therapeutic areas of neurology and immunology diseases. The company's principal products include Cimzia for treating ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Briviact, Vimpat, and Keppra for the treatment of epilepsy partial-onset seizures; Nayzilam, a nasal spray; and Neupro for treating Parkinson's disease and restless legs syndrome. It also offers Zyrtec and Xyzal for the treatment of allergy; Nootropil for the treatment of psycho-organic syndromes or cognitive decline and cortical myoclonus; and Xyrem for use in treating narcolepsy with cataplexy in adult patients. The company's products in pipeline include padsevonil for drug resistant epilepsy; UCB0107 for treating progressive supranuclear palsy; UCB0599 for Parkinson's disease; UCB7858 for auto-inflammatory diseases; bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize S.A. is based in Brussels, Belgium. Address: Allee de la Recherche 60, Brussels, Belgium, 1070
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service